A subsidiary of (Kyowa Hakko KogyoCo Ltd) and privately-held (Murex Corp) jointly announced theysigned an agreement giving Kyowa exclusive rights in Japan tomarket certain Murex products to detect AIDS.    The companies estimated that Japanese clinicians willperform a minimum of 28 mln AIDS tests a year. The Murexproducts must be approved by Japanese authorities before theyare sold in Japan. Reuter&#3;